Biotechnology
10 Amgen finance leaders
These ten Amgen finance leaders include Amgen CFO Peter Griffith, the company's Chief Accounting Officer and its vice president of corporate FP&A, along with finance leaders for regions, a rare disease business unit, R&D and operations. A reader can learn from them how finance supports planning, accounting, deal work and regional operations at Amgen.
Professionals to explore
01—10Bryan Mclachlan
LinkedInExperience: Finance Director Operations · Amgen
Finance Director Operations at Amgen since 2021, described in the profile as a key leader within the Operations Finance team handling financial work from budgeting to forecasting in line with corporate strategy and operational goals. Former Senior Manager Finance Operations (2019–2021) and Finance Manager R&D (2018–2019) at Amgen.
Carlos Mauricio Vera Romero
LinkedInExperience: Chief Financial Officer · Amgen
Chief Financial Officer at Amgen in Colombia since 2021, responsible for financial strategy and operations including accounting and financial reporting, treasury and capital planning, transfer pricing and procurement. Former Latam Regional BPA Head (2019–2021) and Head of Finance (2016–2019) at Sandoz.
Evi Florou
LinkedInExperience: Regional CFO - ELMAC (EMEA, LatAm & Canada) · Amgen
Regional CFO - ELMAC (EMEA, LatAm & Canada) at Amgen since 2023. Former Finance and Sales & Marketing Effectiveness Director, Iberia at Amgen España (2020–2023) and Finance and Sales & Marketing Effectiveness Lead, Greece at Amgen (2016–2020), and former Finance Director, Medical Devices Greece at Johnson & Johnson (2015–2016).
Leandro Gentini
LinkedInExperience: Finance Head Rare Disease Business Unit and Global GCC and CD&A · Amgen
Finance Head Rare Disease Business Unit and Global GCC and CD&A at Amgen since 2024, providing financial leadership for Amgen's US Rare Disease Business Unit (~$5B revenue) and Global Commercial Capabilities. Former Country CFO, Alliance and BD Lead, and Board of Director at Amgen Japan (2023–2024), Country CFO and Board of Director at Amgen Japan (2020–2023) and CFO & Commercial Excellence Lead at Amgen Argentina (2017–2020).
Linda Han Louie
LinkedInExperience: Vice President Finance, Corporate FP&A · Amgen
Vice President Finance, Corporate FP&A at Amgen since 2023. Former Vice President, Finance and Chief Accounting Officer (2020–2023), Executive Director, Global Accounting (2015–2020), Accounting Director, Financial Reporting (2014–2015) and Finance Director - Integration Lead (2011–2014) at Amgen.
Matthew Busch
LinkedInExperience: Chief Accounting Officer (CAO) · Amgen
Chief Accounting Officer (CAO) at Amgen since 2023, with a profile headline of Vice President of Finance and Chief Accounting Officer. Former Vice President Corporate Finance (2021–2023), Executive Director, Corporate Finance (2020–2021), Executive Director, Corporate Accounting (2017–2020) and Director, Technical Accounting and External Reporting (2015–2017) at Amgen.
Migon Houtepen Schoonens
LinkedInExperience: Executive Director Business Development Finance · Amgen
Executive Director Business Development Finance at Amgen since 2024. Former Senior Finance Director Global Commercial Operations Consolidation (2020–2024), CFO - Director Finance & Sales and Marketing Effectiveness at Amgen Iberia (2016–2020) and CFO - Head of Finance at Amgen Netherlands BV (2014–2016), all at Amgen.
Miguel Ramírez Etienne
LinkedInExperience: R&D Finance Director · Amgen
R&D Finance Director at Amgen since 2026. Former Corporate Development & Amgen Ventures Finance Lead (2023–2026), where the profile says the work included in-depth financial analysis to support mergers and acquisitions, in/out licensing and joint ventures, and former Global Finance Lead, Biosimilars Business Unit (2022–2023) at Amgen.
Nathaniel Min
LinkedInExperience: Finance Director, R&D · Amgen
Finance Director, R&D at Amgen since 2018, responsible for supporting the financial strategy of the R&D organization, including oncology, hematology, nephrology, medical affairs and epidemiology; the headline lists LRP planning, clinical study investment reviews and resource allocation. Former Finance Senior Manager, Cost of Sales at Amgen (2014–2018).
Peter Griffith
LinkedInExperience: Executive Vice President, Finance and CFO · Amgen
Executive Vice President, Finance and CFO at Amgen since 2019, listed in the Finance & Accounting department. Former President of Sherwood Canyon Group, LLC (2019), and at EY former Global Vice Chair - Corporate Development (2014–2019), Global Managing Partner, Operations and Finance (2010–2014) and Vice Chair, Pacific Southwest Area (2006–2010).
Choose the right perspective
Choose someone whose finance area matches your decision, since corporate accounting, R&D budgeting, business development and country finance each answer different questions. For how practices differ across markets, favor people who have held finance roles in several Amgen regions or countries.
Questions to take into the conversation
- 01How does a biotech finance team decide how much to invest in late-stage clinical programs versus the rest of the pipeline?
- 02What does finance contribute when a biotech company evaluates licensing deals, acquisitions or joint ventures?
- 03How do regional and country finance leads balance global targets with local market conditions?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal